<DOC>
	<DOCNO>NCT02294773</DOCNO>
	<brief_summary>The aim study assess impact time intrauterine insemination ( IUI ) relation natural surge luteinizing hormone ( LH ) , detect home ovulation predictor kit , pregnancy rate per treatment cycle . The study take place office Midwest Fertility Specialists include patient independently recommend primary physician undergo ovulation induction clomiphene citrate ( CC ) letrozole IUI therapy infertility .</brief_summary>
	<brief_title>Study Evaluating Timing Intrauterine Insemination Relation Positive Home Ovulation Prediction Kit</brief_title>
	<detailed_description>Intrauterine insemination procedure perform physician 's office . During procedure sperm male partner place directly female partner 's uterus around time ovulation ( release oocyte egg ) . Ovulation predictor kit , available counter pharmacy , test presence luteinizing hormone urine . When test result positive , mean hormone present urine . This sign ovulation . Physicians typically choose perform intrauterine insemination either day positive ovulation test day positive ovulation test . The purpose study determine day intrauterine insemination perform influence chance become pregnant .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>All couple consist male female partner undergo CC letrozole cycle plus IUI single infertility center ( Midwest Fertility Specialists ) The female partner must age 2139 Infertile couple include diagnosis ( ) unexplained infertility , mild male factor , ovulatory dysfunction , anovulation Evidence normal uterus least unilateral tubal patency saline infusion sonogram hysterosalpingogram within last 2 year Semen analysis male partner must minimal sperm concentration 10 million per milliliter Recurrent miscarriages Nursing mother Diagnoses primary ovarian failure , diminish ovarian reserve ( indicated blood follicle stimulate hormone &gt; 10 milliInternationalUnits/mL and/or antimullerian hormone level &lt; 0.5 ) , abnormal uterine bleeding undetermined origin , ovarian cyst undetermined origin , stage IV endometriosis , sexhormone dependent tumor Documented bilateral tubal obstruction uncorrected uterine anomaly ( e.g . uterine septum ) Previous gonadotropin use and/or previous treatment vitro fertilization Abnormal semen analysis ( sperm concentration le 10 million per mL ) ejaculatory dysfunction male partner Other uncorrected medical condition female partner would contraindication attempt elective ovulation induction ( e.g. , uncontrolled diabetes , intracranial lesion , thyroid adrenal disease )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Infertility</keyword>
	<keyword>Intrauterine insemination</keyword>
	<keyword>Luteinizing hormone surge</keyword>
</DOC>